Close Notification

Your cart does not contain any items

Urologic An issue of Salvage therapies for Non-Muscle Invasive Bladder Cancer

Badrinath Konety



Not in-store but you can order this
How long will it take?


Elsevier - Health Sciences Division
05 December 2019
Together with Consulting Editor Dr. Samir Taneja, Dr. Badrinath Konety has put together a comprehensive issue that addresses Salvage therapies for Non-Muscle Invasive Bladder Cancer. Expert authors have contributed clinical review articles on the following topics: BCG salvage therapy: Definition and context; Who will respond to BCG? Predictors and nomograms; Identification of candidates for salvage therapy: Definition of BCG Failure ; Predictors of response to Intravesical therapy; Precision medicine for NMIBC; Salvage therapy using BCG derivatives or single agent chemotherapy; Intravesical heated Mitomycin: Biology and clinical utility; Mitomycin derivatives in the salvage setting; Combination intravesical therapy; Intravesical gene therapy; Immunoncology as salvage therapy; Role of IDO inhibitors in salvage therapy; and Novel agents for intravesical therapy. Readers will come away with the clinical information they need to improve outcomes in patients with bladder cancer.
By:   Badrinath Konety
Imprint:   Elsevier - Health Sciences Division
Country of Publication:   United States
Volume:   47-1
Weight:   490g
ISBN:   9780323722568
ISBN 10:   0323722563
Series:   The Clinics: Surgery
Pages:   240
Publication Date:   05 December 2019
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

See Also